Jointechlabs inc
NettetJointechlabs, Inc. Catarina Hadamitzky, Tatiana S. Zaitseva, Nathan Katz, Claire P Edelstein, Manuel T. Escarraman, Dung Nguyen, Michael V. Paukshto To address the limitations of current treatments for secondary lymphedema, a group developed an experimental surgical procedure based on Autologous Lymph Node Fragment (ALNF) … NettetJointechlabs Inc. posted images on LinkedIn. Principal Chief Executive Officer at BIONICA USA 5h
Jointechlabs inc
Did you know?
Nettet30. okt. 2024 · JointechLabs Scientific. Sep 2009 - Sep 20145 years 1 month. Skokie, Illinois, United States. Scientific development toward … Nettet20. okt. 2024 · CHICAGO, Oct. 20, 2024 /PRNewswire/ -- Jointechlabs, Inc., a Regenerative Medicine Solutions company announced a Vienna -based subsidiary named JointechPlus GmbH. They also announced research ...
Nettet11. jan. 2024 · Jointechlabs, Inc. Katz, N., Koukharenko, V. and Geldner, P. Testing the assumption that adding purified autologous adipose-derived mesenchymal stem cells (ADMSC) could improve the survival of fat transplants. Home » Industry Research » Comparison of Different Conditions for the Survival of Human Abdominal Fat in vitro. Nettet26. aug. 2024 · Jointechlabs Inc. is an emerging leader in point-of-care regenerative and rejuvenation medicine therapies. We have patented, portable medicine products that enable personalized therapies. Our medical device allows doctors, clinics, and hospitals to provide safe- and cost-effective non-surgical regenerative and healing treatments for …
Nettet8. jun. 2024 · Jointechlabs, Inc. has raised a total of $1.7M in funding over 3 rounds. Their latest funding was raised on Jun 8, 2024 from a Seed round. Jointechlabs, Inc. is funded by 4 investors. SOSV and EXPERT DOJO are the most recent investors. Funding Rounds Number of Funding Rounds 3 Total Funding Amount $1.7M NettetJointechlabs Inc., Chicago, Illinois. 287 liker dette · 1 snakker om dette. Jointechlabs develops point-of-care regenerative medicine therapies such as... Jointechlabs …
Nettet28. mar. 2024 · Jointechlabs is an emerging leader in point-of-care regenerative medicine therapies worldwide. FDA-cleared: MiniTC® for microfat. CE-Mark pending: Mini-Stem … Jointechlabs is an emerging world leader in point-of-care regenerative medicine … See additional insights by Dr. Nathan Katz, CEO, Jointechlabs, Inc. Our products …
NettetNishit Pancholi posted images on LinkedIn. Inventor / Founder / Regenerative Medicine / Clinical Development Professional jerusalem arise global awakeningNettet19 timer siden · Running the company is having endless stuff on the plate. Yet, I can't give up the joy of getting into the lab, running sample tests, taking charge of bench… jerusalema romaniaNettetFind company research, competitor information, contact details & financial data for Jointechlabs, Inc. of North Barrington, IL. Get the latest business insights from Dun & … lamesa asianaNettet26. aug. 2024 · Jointechlabs Inc. is an emerging leader in point-of-care regenerative and rejuvenation medicine therapies. We have patented, portable medicine products that … jerusalema (remix) master kg feat. burna boy & nomcebo zikodeNettetJointechlabs Inc. ™ 🔰MiniTC® fits any existing workflow. 👉 It's compact 👉 Practical 👉 Highly efficient for providers and patients To learn more:… lamesa asiana hotel dubaiNettetOverview Doing Business As:Jointechlabs, Inc. Company Description:Jointechlabs, Inc. is located in North Barrington, IL, United States and is part of the Medical Equipment and Supplies Manufacturing Industry. Jointechlabs, Inc. has 6 total employees across all of its locations and generates $514,681 in sales (USD). jerusalema remix ponifasio samoaNettetRegenerative therapies startup Jointechlabs Inc. has won the U.S. FDAâ s nod for its MiniTC point-of-care fat tissue processing device. The 510(k)-cleared product is … lamesa at upuan